MCWA
GILD icon

Meadow Creek Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Meadow Creek Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Sell
2,245
-568
-20% -$74.8K 0.17% 112
2026
Q1 		$392K Buy
2,813
+603
+27% +$84.4K 0.25% 85
2025
Q4 		$271K Buy
2,210
+276
+14% +$33.5K 0.17% 111
2025
Q3 		$228K Buy
1,934
+16
+0.8% +$1.82K 0.15% 125
2025
Q2 		$213K Buy
+1,918
New +$204K 0.14% 134

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meadow Creek Wealth Advisors's GILD Position: Q2 2026 in Review

Meadow Creek Wealth Advisors reduced its Gilead Sciences (GILD) stake by 20% in Q2 2026, selling an estimated $74.8K and leaving 2,245 shares worth $284K. The position accounts for 0.17% of the portfolio, ranked #112.

Meadow Creek Wealth Advisors first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $392K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Meadow Creek Wealth Advisors held 2,245 shares of Gilead Sciences worth $284K as of Q2 2026.
  • Meadow Creek Wealth Advisors sold 568 Gilead Sciences shares in Q2 2026, an estimated $74.8K.
  • Gilead Sciences made up 0.17% of Meadow Creek Wealth Advisors's portfolio in Q2 2026, its #112 holding.
  • Meadow Creek Wealth Advisors first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Meadow Creek Wealth Advisors's Gilead Sciences position peaked at $392K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Meadow Creek Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.